Valuation: StimCell Energetics Inc.

Market Cap 5.83M 5.12M 4.77M 4.37M 8.22M 562M 8.34M 56.6M 22.11M 276M 21.9M 21.43M 955M P/E 2026 *
-6.9x
P/E 2027 * -13.8x
Enterprise Value 6.63M 5.83M 5.42M 4.97M 9.34M 639M 9.49M 64.35M 25.14M 314M 24.91M 24.37M 1.09B EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
28.33%
Yield 2026 *
-
Yield 2027 * -
1 day-12.10%
Current month-12.10%
1 month-21.14%
3 months-6.44%
6 months-40.00%
Current year-31.00%
1 month 0.28
Extreme 0.276
0.35
Current year 0.28
Extreme 0.276
0.48
1 year 0.25
Extreme 0.2501
0.48
3 years 0
Extreme 0.0015
13.97
5 years 0
Extreme 0
13.97
10 years 0
Extreme 0
25.35
Manager TitleAgeSince
Chief Executive Officer 56 12/12/2023
Director of Finance/CFO 48 24/11/2014
Director TitleAgeSince
Chairman 78 26/02/2024
Director/Board Member 62 08/06/2020
Director/Board Member 56 12/12/2023
Date Insider Type Main position Quantity % Market Cap.
18/12/25 Sell

Director

16,667 0.0807%
17/03/25 Tax

Director

60,841,472 307.0278%
25/02/25 Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
-12.10%0.00%+2.22%+119.05% 5.83M
+1.07%-3.49%-3.25%+12.87% 46.86B
+0.25%+1.65%+408.41%+629.49% 40.23B
-0.27%+4.45%+9.93%+66.92% 36.23B
+0.35%+0.87%+3.60%-8.81% 34.72B
+3.14%+1.02%+3.37%+38.15% 27.89B
-0.73%+11.84%+31.97%+143.53% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%+0.76%+8.50% 13.12B
-2.68%-2.49%-15.00%-31.68% 12.7B
Average -1.01%+0.75%+49.11%+108.67% 24.53B
Weighted average by Cap. +0.48%+0.91%+75.31%+136.64%

Financials

2026 *2027 *
Net sales - -
Net income -792M -696M -647M -594M -1.12B -76.31B -1.13B -7.69B -3B -37.52B -2.97B -2.91B -130B -510M -448M -417M -382M -718M -49.11B -729M -4.95B -1.93B -24.15B -1.91B -1.87B -83.48B
Net Debt 800K 703K 653K 600K 1.13M 77.04M 1.14M 7.76M 3.03M 37.88M 3M 2.94M 131M 800K 703K 653K 600K 1.13M 77.04M 1.14M 7.76M 3.03M 37.88M 3M 2.94M 131M
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume
23/07/26 $0.000000 - 80
22/07/26 $0.000000 - 67

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STME Stock